1 results match your criteria: "Central TB Research Institute of Russian Academy of Medical Sciences[Affiliation]"

Setting: Joint World Health Organization (WHO) projects in Vladimir and Orel regions, Russia.

Objective: To study the prevalence of extensively drug-resistant (XDR) tuberculosis (TB).

Methods: Drug susceptibility testing of second-line drugs (ofloxacin, kanamycin, capreomycin, ethionamide, cycloserine and para-aminosalicylic acid) was performed on isolates from multidrug-resistant TB cases from 1 January to 31 December 2006.

View Article and Find Full Text PDF